Health Canada
- Status: approved
🇨🇦 Prasugrel based short DAPT in Canada
Prasugrel based short DAPT (Prasugrel based short DAPT) regulatory status in Canada.
Marketing authorisation
Prasugrel based short DAPT in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Frequently asked questions
Is Prasugrel based short DAPT approved in Canada?
Yes. Health Canada has authorised it.
Who is the marketing authorisation holder for Prasugrel based short DAPT in Canada?
Research Maatschap Cardiologen Rotterdam Zuid is the originator. The local marketing authorisation holder may differ — check the official source linked above.